Trial intelligence / Profile preview

Fractional CO₂ Laser vs CO₂ Laser + PRP for Genitourinary Syndrome of Menopause

NCT07863739Completed

Sponsor
National and Kapodistrian University of Athens
Start
Jun 2023
Primary completion
Apr 2025
Countries
1
01

Overview

Open-label trial of autologous platelet-rich plasma in genitourinary syndrome of menopause (GSM) (2 arms), sponsored by National and Kapodistrian University of Athens. Primary endpoint: Change in Vaginal Dryness Severity. Started Jun 2023; status: completed.

02

Drugs

autologous platelet-rich plasma
03

Conditions

genitourinary syndrome of menopause (GSM)

Beyond the preview

Go deeper on NCT07863739.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07863739.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call